...
首页> 外文期刊>Journal of Medicinal Chemistry >Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.
【24h】

Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.

机译:花青素相关拮抗剂的设计,合成和生物学活性。哌嗪的哌嗪和呋喃单元对α1-肾上腺素受体亚型选择性的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Prazosin-related quinazolines 4-20 were synthesized, and their biological profiles at alpha1-adrenoreceptor subtypes were assessed by functional experiments in isolated rat vas deferens (alpha1A), spleen (alpha1B), and aorta (alpha1D) and by binding assays in CHO cells expressing human cloned alpha1-adrenoreceptor subtypes. The replacement of piperazine and furan units of prazosin (1) by 1, 6-hexanediamine and phenyl moieties, respectively, affording 3-20, markedly affected both affinity and selectivity for alpha1-adrenoreceptor subtypes in functional experiments. Cystazosin (3), bearing a cystamine moiety, was a selective alpha1D-adrenoreceptor antagonist being 1 order of magnitude more potent at alpha1D-adrenoreceptors (pA2, 8.54 +/- 0.02) than at the alpha1A- (pA2, 7.53 +/- 0.01) and alpha1B-subtypes (pA2, 7.49 +/- 0. 01). The insertion of substituents on the furan ring of 3, as in compounds 4 and 5, did not improve the selectivity profile. The simultaneous replacement of both piperazine and furan rings of 1 gave 8 which resulted in a potent, selective alpha1B-adrenoreceptor antagonist (85- and 15-fold more potent than at alpha1A- and alpha1D-subtypes, respectively). The insertion of substituents on the benzene ring of 8 affected, according to the type and the position of the substituent, affinity and selectivity for alpha1-adrenoreceptors. Consequently, the insertion of appropriate substituents in the phenyl ring of 8 may represent the basis of designing new selective ligands for alpha1-adrenoreceptor subtypes. Interestingly, the finding that polyamines 11, 16, and 20, bearing a 1,6-hexanediamine moiety, retained high affinity for alpha1-adrenoreceptor subtypes suggests that the substituent did not give rise to negative interactions with the receptor. Finally, binding assays performed with selected quinazolines (2, 3, and 14) produced affinity results, which were not in agreement with the selectivity profiles obtained from functional experiments. This rather surprising and unexpected finding may be explained by considering neutral and negative antagonism.
机译:合成了与Prazosin相关的喹唑啉4-20,并通过在分离的大鼠输精管(alpha1A),脾脏(alpha1B)和主动脉(alpha1D)中进行功能性实验以及通过在CHO细胞中进行结合测定来评估其在α1-肾上腺素受体亚型的生物学谱表达人类克隆的α1-肾上腺素受体亚型。用1,6-己二胺和苯基部分分别取代哌唑嗪(1)的哌嗪和呋喃单元,得到3-20,显着影响了功能实验中对α1-肾上腺素受体亚型的亲和力和选择性。带有胱胺部分的胱氨酸(3)是一种选择性的α1D肾上腺素受体拮抗剂,对α1D肾上腺素受体(pA2,8.54 +/- 0.02)的作用比对α1A-(pA2,7.53 +/- 0.01)的作用高1个数量级。 )和alpha1B子类型(pA2,7.49 +/- 0. 01)。如化合物4和5中那样,在3的呋喃环上插入取代基没有改善选择性。哌嗪和呋喃环同时被替换为1时得到8,这产生了一种有效的,选择性的alpha1B-肾上腺素受体拮抗剂(分别比alpha1A-和alpha1D亚型的效力高85-和15-倍)。根据取代基的类型和位置,对α1-肾上腺素受体的亲和力和选择性,受影响的取代基在8的苯环上的插入。因此,在8的苯环中插入适当的取代基可以代表为α1-肾上腺素受体亚型设计新的选择性配体的基础。有趣的是,发现带有1,6-己二胺部分的多胺11、16和20对α1-肾上腺素受体亚型保持高亲和力,这一发现表明该取代基不会引起与受体的负相互作用。最后,用选定的喹唑啉(2、3和14)进行的结合测定产生了亲和力结果,这与从功能性实验中获得的选择性谱图不一致。可以通过考虑中性和负面拮抗来解释这一相当令人惊讶和出乎意料的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号